Meeting Coverage

ASCO Video Pearls: Immunotherapy

Video Pearls from the American Society of Clinical Oncology

Vorasidenib for Low-Grade Glioma Doubles Progression-Free Survival

INDIGO demonstrates major treatment advance for patients with IDH1/2-mutant disease

image

Latest ASCO Video Pearls: Immunotherapy Meeting Coverage

Sparing Melanoma Survivors From Overexposure to Surveillance Imaging

Study examined follow-up scans every 6-12 months instead of the standard 3-month interval

June 23, 2023